1. Home
  2. ASTI vs ENSC Comparison

ASTI vs ENSC Comparison

Compare ASTI & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascent Solar Technologies Inc.

ASTI

Ascent Solar Technologies Inc.

HOLD

Current Price

$2.93

Market Cap

5.7M

Sector

Technology

ML Signal

HOLD

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

HOLD

Current Price

$1.43

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTI
ENSC
Founded
2005
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7M
6.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ASTI
ENSC
Price
$2.93
$1.43
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
364.3K
415.8K
Earning Date
11-10-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$61,134.00
$4,487,973.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
36.85
1.51
52 Week Low
$1.10
$1.26
52 Week High
$4.41
$10.96

Technical Indicators

Market Signals
Indicator
ASTI
ENSC
Relative Strength Index (RSI) 78.92 33.84
Support Level $1.58 $1.26
Resistance Level $3.64 $1.69
Average True Range (ATR) 0.36 0.15
MACD 0.19 -0.01
Stochastic Oscillator 76.79 27.97

Price Performance

Historical Comparison
ASTI
ENSC

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is engaged in the manufacturing, and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: